"Psychomotor Agitation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
Descriptor ID |
D011595
|
MeSH Number(s) |
C10.597.350.600 C10.597.606.881.700 C23.888.592.350.600 C23.888.592.604.882.700 F01.700.875.700
|
Concept/Terms |
Psychomotor Agitation- Psychomotor Agitation
- Restlessness
- Psychomotor Hyperactivity
- Hyperactivity, Psychomotor
- Psychomotor Restlessness
- Restlessness, Psychomotor
- Agitation, Psychomotor
- Excitement, Psychomotor
- Psychomotor Excitement
|
Below are MeSH descriptors whose meaning is more general than "Psychomotor Agitation".
Below are MeSH descriptors whose meaning is more specific than "Psychomotor Agitation".
This graph shows the total number of publications written about "Psychomotor Agitation" by people in this website by year, and whether "Psychomotor Agitation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 1 | 3 |
1997 | 1 | 0 | 1 |
1998 | 2 | 0 | 2 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2005 | 1 | 1 | 2 |
2006 | 4 | 2 | 6 |
2007 | 1 | 2 | 3 |
2008 | 1 | 1 | 2 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 1 | 3 |
2013 | 1 | 0 | 1 |
2014 | 3 | 0 | 3 |
2015 | 6 | 1 | 7 |
2016 | 2 | 1 | 3 |
2017 | 3 | 0 | 3 |
2018 | 2 | 0 | 2 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psychomotor Agitation" by people in Profiles.
-
Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium. Expert Opin Drug Saf. 2021 Feb; 20(2):123-138.
-
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial. Alzheimers Dement. 2019 11; 15(11):1427-1436.
-
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2018 11; 33(7):450-457.
-
Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force. J Prev Alzheimers Dis. 2018; 5(2):98-102.
-
Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting. Pharmacotherapy. 2018 01; 38(1):139-151.
-
Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients. Crit Care Nurs Q. 2017 Oct/Dec; 40(4):344-362.
-
Pain, Agitation, and Delirium Guidelines: Interprofessional Perspectives to Translate the Evidence. Dimens Crit Care Nurs. 2017 May/Jun; 36(3):164-173.
-
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Br J Clin Pharmacol. 2016 09; 82(3):784-92.
-
Principal components analysis of agitation outcomes in Alzheimer's disease. J Psychiatr Res. 2016 08; 79:4-7.
-
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial. Am J Psychiatry. 2016 May 01; 173(5):465-72.